A drug that increases expression of BCL2 related cell death agonists for treating cancer

摘要

The present invention provides a drug that increases the expression of bad for use in the treatment of cancer in combination with chemotherapeutic agents, and the drug is selected from the group consisting of 6 -. Beta. - nartilexol, naloxone, methylnartrexone or the pharmaceutically acceptable salt.